PRESS RELEASE
News
-
-
-
PRESS RELEASE
Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Onco-Innovations Limited reports progress in scale-up and development for ONC010 oncology program, focusing on A83 and B4 precursor components. Collaboration with Dalton Pharma Services aims at future GMP production -
-
PRESS RELEASE
EQS-Adhoc: ams OSRAM announces the successful pricing of EUR 1 billion 7.250% Senior Notes due 2032, supporting the path to positive Free Cash Flow from 2027 onwards
ams OSRAM successfully prices EUR 1 billion 7.250% Senior Notes due 2032 to support path to positive Free Cash Flow from 2027 onwards -
-
-
-
-
